<?xml version="1.0" encoding="UTF-8"?><CAS version="2"><uima.cas.Sofa _indexed="0" _id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="P10965135A0735 Promoter activity was dose-dependently inhibited by cotransfection with either ras or mos oncogenes, but oncogene inhibition was reversed and the overall activity increased when cells were treated with the MAP kinase kinase (MKK) inhibitor PD98059."/><uima.tcas.DocumentAnnotation _indexed="1" _id="8" _ref_sofa="1" begin="0" end="263" language="x-unspecified"/><edu.cmu.tanl.type.gene _indexed="1" _id="13" _ref_sofa="1" begin="70" end="72" Gene="ras"/><edu.cmu.tanl.type.gene _indexed="1" _id="18" _ref_sofa="1" begin="75" end="86" Gene="mos oncogenes"/><edu.cmu.tanl.type.gene _indexed="1" _id="23" _ref_sofa="1" begin="177" end="191" Gene="MAP kinase kinase"/><edu.cmu.tanl.type.gene _indexed="1" _id="28" _ref_sofa="1" begin="193" end="195" Gene="MKK"/></CAS>